Sign in

CIK 0000078003

  • Large accelerated filer
Ticker
PFE
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
135315170
Phone
+1 212-733-2323
Business address
66 HUDSON BOULEVARD EAST, NEW YORK, NY, 10001-2192
Former names
PFIZER INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-22 BOURLA ALBERT Chairman & CEO Option exercise · Stock Appreciation Rights −238,399 0
2025-02-22 LANKLER DOUGLAS M Executive Vice President Option exercise +85,824 $30.17 $2.6M 232,775
2025-02-22 LANKLER DOUGLAS M Executive Vice President Shares withheld for taxes −3,334 $26.30 $88K 229,441
2025-02-22 LANKLER DOUGLAS M Executive Vice President Shares withheld for taxes −76,565 $26.08 $2.0M 152,876
2025-02-22 LANKLER DOUGLAS M Executive Vice President Option exercise · Stock Appreciation Rights −85,824 0
2025-02-22 SAHNI PAYAL Executive Vice President Option exercise +12,714 $30.17 $384K 37,099
2025-02-22 SAHNI PAYAL Executive Vice President Shares withheld for taxes −568 $26.30 $15K 36,531
2025-02-22 SAHNI PAYAL Executive Vice President Shares withheld for taxes −11,343 $26.08 $296K 25,188
2025-02-22 SAHNI PAYAL Executive Vice President Option exercise · Stock Appreciation Rights −12,714 0
2025-02-22 SUSMAN SALLY Executive Vice President Option exercise +63,573 $30.17 $1.9M 225,184
2025-02-22 SUSMAN SALLY Executive Vice President Shares withheld for taxes −2,785 $26.30 $73K 222,399
2025-02-22 SUSMAN SALLY Executive Vice President Shares withheld for taxes −56,715 $26.08 $1.5M 165,684
2025-02-22 SUSMAN SALLY Executive Vice President Option exercise · Stock Appreciation Rights −63,573 0
2025-02-22 BOSHOFF CHRISTOFFEL President, R&D Option exercise +8,741 $30.17 $264K 159,085
2025-02-22 BOSHOFF CHRISTOFFEL President, R&D Shares withheld for taxes −340 $26.30 $9K 158,745
2025-02-22 BOSHOFF CHRISTOFFEL President, R&D Shares withheld for taxes −7,798 $26.08 $203K 150,947
2025-02-22 BOSHOFF CHRISTOFFEL President, R&D Option exercise · Stock Appreciation Rights −8,741 0
2025-02-13 BOURLA ALBERT Chairman & CEO Grant or award · Phantom Stock Units SSP +625 $25.64 $16K 702,791
2025-02-13 BLAYLOCK RONALD E Director Purchase +19,457 $25.65 $499K 27,707
2025-01-31 BOSHOFF CHRISTOFFEL President, R&D Shares withheld for taxes −12,038 $26.52 $319K 150,344

Page 12 of 15 · 291 trades